Wegovy vs Mounjaro: Key Differences for UK Patients
Is Wegovy or Mounjaro Better Through Private Prescription Routes?
The private prescription pathway offers significant advantages when choosing between Wegovy and Mounjaro for weight management. Unlike the NHS route requiring GP referral to specialist weight management services with 6+ month waiting lists, private prescription provides immediate access to both medications. Your clinical assessment takes just 3 minutes online, followed by prescriber review within 24-72 hours. This efficiency means you can start your chosen treatment without the frustration of lengthy delays or strict NHS eligibility criteria that often exclude patients with BMI between 27-30.
Both Wegovy and Mounjaro are prescription-only medicines available through our GPhC-registered pharmacy (#9012878), ensuring you receive the same quality medication dispensed through NHS channels. The key difference lies in speed and convenience—private prescription eliminates bureaucratic barriers whilst maintaining clinical safety through proper medical oversight. Whether you choose Wegovy's established GLP-1 mechanism or Mounjaro's newer dual-agonist approach, private prescription ensures faster access to evidence-based weight management support.
Wegovy vs Mounjaro Pricing: Transparent UK Private Costs
When comparing costs for Wegovy versus Mounjaro privately, Wegovy offers clear pricing structure starting at £79.99 for the 0.25mg starter dose with discount code FIRST40 applied at checkout. The dose escalation follows: 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). Our Intro Trio bundle provides the first three months (0.25mg, 0.5mg, 1mg) for £299.99, whilst returning customers use code DOSE25 for ongoing savings. These transparent prices eliminate the uncertainty often associated with private weight management costs.
Mounjaro pricing varies by provider, but Wegovy's established market presence often results in more competitive private prescription costs. Our bundle options like the Progress Duo (0.5mg & 1mg for £189.99) and Ultimate Stability Trio (three months of 2.4mg maintenance for £649.99) provide supply security without frequent reordering. The convenience of Stock Available and next-day delivery adds value beyond simple cost comparison, especially considering medication shortages that occasionally affect both treatments.
Clinical Evidence: How Wegovy and Mounjaro Compare in Trials
In the STEP clinical trials, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved an average weight reduction of approximately 15% at 68 weeks, according to research by Wilding et al., published in NEJM, 2021. The STEP programme demonstrated consistent efficacy across different patient populations, including those with type 2 diabetes (STEP 2) and patients receiving intensive behavioural therapy (STEP 3). These trials established Wegovy's cardiovascular benefits, with the SELECT study showing a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed promising results for tirzepatide, though direct comparison between trial outcomes isn't clinically appropriate due to different study designs, patient populations, and endpoints. Both medications require prescription-only medicine protocols and work alongside lifestyle modifications rather than as standalone treatments. Your prescriber can review which clinical evidence profile better matches your individual health circumstances and treatment goals.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone responsible for appetite regulation and blood sugar control. When injected once weekly, it works on brain appetite centres to reduce hunger signals and promote feelings of fullness after smaller meals. This mechanism may help reduce food cravings and support portion control, making it easier to maintain the reduced-calorie diet essential for weight management success. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike quick fixes or unregulated supplements, Wegovy's scientifically-proven mechanism addresses the biological drivers of appetite and food intake that make long-term weight management challenging.
Simple Ordering Process: From Assessment to Delivery
Ordering Wegovy or Mounjaro privately through EverydayMeds involves a streamlined three-step process designed for convenience and clinical safety. The initial online assessment takes approximately 3 minutes, covering medical history, current medications, and weight management goals to ensure prescription appropriateness. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring proper clinical oversight without unnecessary delays. Once approved, your medication is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication efficacy. The entire process from assessment to receiving your first dose typically takes 4-5 days, compared to months through traditional NHS referral pathways.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro requires refrigeration return within 21 days. This advantage makes Wegovy more suitable for frequent travellers or those with limited reliable refrigeration access. The FlexTouch pen system is pre-filled and disposable, requiring no mixing or complex preparation—simply attach a new needle for each weekly injection. Dose escalation follows a mandatory schedule over 16 weeks, starting at 0.25mg and gradually increasing to the 2.4mg maintenance dose to minimise potential side effects. Both medications require careful adherence to the escalation protocol, as skipping doses or advancing too quickly can increase the likelihood of gastrointestinal side effects.
Why Private Prescription Makes Sense for Wegovy vs Mounjaro Decisions
The decision between Wegovy and Mounjaro often requires personalised medical guidance that private prescription facilitates more effectively than rushed NHS appointments. Private prescribers have time to discuss your lifestyle, work schedule, travel requirements, and previous weight management experiences in detail. This comprehensive approach helps determine whether Wegovy's single-target mechanism or Mounjaro's dual-agonist approach better suits your individual physiology and circumstances.
Additionally, private prescription provides flexibility to switch between treatments if your initial choice doesn't produce expected results or causes intolerable side effects. NHS pathways often involve lengthy re-referral processes for treatment changes, whilst private prescription allows more responsive clinical management. The investment in private prescription pays dividends through faster access, personalised care, and the ability to optimise treatment without bureaucratic delays.
Expert Guidance: Making Your Wegovy vs Mounjaro Choice
Rather than declaring one medication superior, the question "is Wegovy or Mounjaro better" depends entirely on individual patient factors including medical history, lifestyle, and treatment response. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option aligns with your specific needs through detailed clinical assessment. Our team considers factors like your previous medication experiences, travel requirements, injection preferences, and any existing health conditions that might influence treatment selection. We provide ongoing support throughout your weight management journey, with the flexibility to adjust treatment approaches based on your progress and any side effects experienced. Start your assessment today using code FIRST40 for new customers, and take the first step towards evidence-based weight management with proper medical supervision through our GPhC-registered pharmacy (#9012878).
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
